ADMA Biologics Inc Retained Earnings (Accumulated Deficit) 2013-2024 | ADMA
ADMA Biologics Inc retained earnings (accumulated deficit) for the quarter ending June 30, 2024 were $-0.456B, a 7.08% decline year-over-year.
- ADMA Biologics Inc retained earnings (accumulated deficit) for 2023 were $-0.506B, a 5.91% increase from 2022.
- ADMA Biologics Inc retained earnings (accumulated deficit) for 2022 were $-0.478B, a 15.99% increase from 2021.
- ADMA Biologics Inc retained earnings (accumulated deficit) for 2021 were $-0.412B, a 21.04% increase from 2020.